INFLUENCE OF POLYOXIDONIUM, Poly(I:C), DALARGIN ON THE PROTECTIVE EFFICACY OF YERSINIA PESTIS VACCINE STRAIN EV LINE NIIEG IN EXPERIMENTAL PLAGUE

Abstract

In this study, the use of immunoadjuvants polyoxidonium (azoximer bromide), Poly (I:C) as a synthetic analog of double-stranded RNA (TLR3 ligand), and synthetic analog of leu-enkephalin dalargin (DA) was experimentally investigated for their potential to minimize ImD50 Yersinia pestis vaccine strain EV line NIIEG co-administrated via invasive (subcutaneous) and noninvasive (intranasal) routes in lethal bubonic and pneumonic models of plague followed by challenge with virulent Y. pestis strains of the main and non-main subspecies from various natural plague foci. The data showed that in all cases immunoadjuvants significantly increased protective efficacy of Y. pestis vaccine strain EV line NIIEG co-administrated to BALB/c inbreed mice in case of lethal challenge with virulent Y. pestis strains in spite of varying magnitude of humoral immune response. Y. pestis vaccine strain EV line NIIEG formulated with polyoxidonium provided more effective protection against lethal challenge with wild-type high virulent strain Y. pestis in pneumonic model of plague. Polyoxidonium introduced into vaccine formula resulted in four-fold rise in total survival in animals with pneumonic plaque. Feasibility of using immunoadjuvants for regimen of specific and urgent plaque prevention is justified.